Bioactivity:

CD161 is a potent, selective, and orally bioavailable BET bromodomain inhibitor (IC50s: 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2) with good anticancer activity.

CAS nr:

1627716-22-6

Purity:

98%

Molecular Weight:

435,48

SMILES:

CC1=NC(C2=CC=NC3=CC=CC=C23)=C4C(NC5=C4C=C(OC)C(C6=C(C)ON=C6C)=C5)=N1

Formula:

C26H21N5O2

Pathway:

Others

Target:

Others